TransMedics to Present at Upcoming Investor Conferences
TransMedics Group (TMDX) announced that management is scheduled to participate in fireside chats at three upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
TransMedics Group (TMDX) announced that management is scheduled to participate in fireside chats at three upcoming investor conferences. The events are Stifel in New York on November 10, 2026, at 10:40 a.m. EST; Jefferies in London on November 17 at 7:00 a.m. EST; and Piper Sandler in New York on December 1 at 4:30 p.m. EST. Live and archived webcasts will be available on the company's investor website.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Event: Stifel 2026 Healthcare Conference
Date: Tuesday, November 10, 2026
Time: 10:40 a.m. EST
Event: Jefferies Global Healthcare Conference
Date: Tuesday, November 17, 2026
Time: 7:00 a.m. EST
Event: Piper Sandler 38th Annual Healthcare Conference
Date: Tuesday, December 1, 2026
Time: 4:30 p.m. EST
A live and archived webcast of the fireside chats will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. The Company's standard investor presentation is also available through this link.
About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.
Investor Contact:
Brian Johnston
Hannah Jeffrey
332-895-3222
Investors@transmedics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-present-at-upcoming-investor-conferences-302924287.html
SOURCE TransMedics Group, Inc.